128 related articles for article (PubMed ID: 37207394)
1. Accumulation and metabolization of the antidepressant venlafaxine and its main metabolite o-desmethylvenlafaxine in non-target marine organisms Holothuria tubulosa, Anemonia sulcata and Actinia equina.
Del Carmen Gómez-Regalado M; Martín J; Hidalgo F; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
Mar Pollut Bull; 2023 Jul; 192():115055. PubMed ID: 37207394
[TBL] [Abstract][Full Text] [Related]
2. Bioconcentration of pharmaceuticals in benthic marine organisms (Holothuria tubulosa, Anemonia sulcata and Actinia equina) exposed to environmental contamination by atenolol and carbamazepine.
Del Carmen Gómez-Regalado M; Martín J; Hidalgo F; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
Environ Toxicol Pharmacol; 2023 Jun; 100():104147. PubMed ID: 37182729
[TBL] [Abstract][Full Text] [Related]
3. Uptake and depuration of three common antibiotics in benthic organisms: Sea cucumber (Holothuria tubulosa), snakelocks anemone (Anemonia sulcata) and beadlet anemone (Actinia equina).
Gómez-Regalado MDC; Martín J; Hidalgo F; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
Environ Res; 2023 Sep; 232():116082. PubMed ID: 37164284
[TBL] [Abstract][Full Text] [Related]
4. In vivo exposure of marine mussels to venlafaxine: bioconcentration and metabolization.
Gomez E; Boillot C; Martinez Bueno MJ; Munaron D; Mathieu O; Courant F; Fenet H
Environ Sci Pollut Res Int; 2021 Dec; 28(48):68862-68870. PubMed ID: 34278554
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancy.
ter Horst PG; Larmené-Beld KH; Bosman J; van der Veen EL; Wieringa A; Smit JP
J Clin Pharm Ther; 2014 Oct; 39(5):541-4. PubMed ID: 24989434
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine exposure in the sea anemones Anemonia sulcata and Actinia equina: Metabolite identification and physiological responses.
Vitale D; Picó Y; Spanò N; Torreblanca A; Del Ramo J
Sci Total Environ; 2020 Nov; 744():140891. PubMed ID: 32711318
[TBL] [Abstract][Full Text] [Related]
7. Assessing bioaccumulation potential of personal care, household and industrial products in a marine echinoderm (Holothuria tubulosa).
Martín J; Hidalgo F; Alonso E; García-Corcoles MT; Vílchez JL; Zafra-Gómez A
Sci Total Environ; 2020 Jun; 720():137668. PubMed ID: 32325598
[TBL] [Abstract][Full Text] [Related]
8. Glycine functionalized multiwall carbon nanotubes as a novel hollow fiber solid-phase microextraction sorbent for pre-concentration of venlafaxine and o-desmethylvenlafaxine in biological and water samples prior to determination by high-performance liquid chromatography.
Ghorbani M; Chamsaz M; Rounaghi GH
Anal Bioanal Chem; 2016 Jun; 408(16):4247-56. PubMed ID: 27108286
[TBL] [Abstract][Full Text] [Related]
9. Diversity and antimicrobial potential in sea anemone and holothurian microbiomes.
León-Palmero E; Joglar V; Álvarez PA; Martín-Platero A; Llamas I; Reche I
PLoS One; 2018; 13(5):e0196178. PubMed ID: 29742123
[TBL] [Abstract][Full Text] [Related]
10. Enantiospecific toxicity, distribution and bioaccumulation of chiral antidepressant venlafaxine and its metabolite in loach (Misgurnus anguillicaudatus) co-exposed to microplastic and the drugs.
Qu H; Ma R; Wang B; Yang J; Duan L; Yu G
J Hazard Mater; 2019 May; 370():203-211. PubMed ID: 29706475
[TBL] [Abstract][Full Text] [Related]
11. β-cyclodextrin improve the tolerant of freshwater algal Spiny Scenedesmus to chiral drugs venlafaxine and its metabolite.
Wang W; Gong W; Zhou S; Han J; Qi D; Qu H
J Hazard Mater; 2020 Nov; 399():123076. PubMed ID: 32540709
[TBL] [Abstract][Full Text] [Related]
12. The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes.
Jiang F; Kim HD; Na HS; Lee SY; Seo DW; Choi JY; Ha JH; Shin HJ; Kim YH; Chung MW
Psychopharmacology (Berl); 2015 Jun; 232(11):1899-909. PubMed ID: 25510856
[TBL] [Abstract][Full Text] [Related]
13. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients.
Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW
Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
Hermann M; Hendset M; Fosaas K; Hjerpset M; Refsum H
Eur J Clin Pharmacol; 2008 May; 64(5):483-7. PubMed ID: 18214456
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of venlafaxine extended release 75 mg and desvenlafaxine 50 mg in healthy CYP2D6 extensive and poor metabolizers: a randomized, open-label, two-period, parallel-group, crossover study.
Nichols AI; Focht K; Jiang Q; Preskorn SH; Kane CP
Clin Drug Investig; 2011; 31(3):155-67. PubMed ID: 21288052
[TBL] [Abstract][Full Text] [Related]
16. Rapid high-performance liquid chromatographic measurement of venlafaxine and O-desmethylvenlafaxine in human plasma. Application to management of acute intoxications.
Matoga M; Pehourcq F; Titier K; Dumora F; Jarry C
J Chromatogr B Biomed Sci Appl; 2001 Sep; 760(2):213-8. PubMed ID: 11530979
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
18. Effects of age and gender on venlafaxine and O-desmethylvenlafaxine pharmacokinetics.
Klamerus KJ; Parker VD; Rudolph RL; Derivan AT; Chiang ST
Pharmacotherapy; 1996; 16(5):915-23. PubMed ID: 8888087
[TBL] [Abstract][Full Text] [Related]
19. Insights on the metabolization of the antidepressant venlafaxine by meagre (Argyrosomus regius) using a combined target and suspect screening approach.
Santos LHMLM; Maulvault AL; Jaén-Gil A; Marques A; Barceló D; Rodríguez-Mozaz S
Sci Total Environ; 2020 Oct; 737():140226. PubMed ID: 32575024
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics of venlafaxine when given in a twice-daily regimen.
Troy SM; Parker VD; Fruncillo RJ; Chiang ST
J Clin Pharmacol; 1995 Apr; 35(4):404-9. PubMed ID: 7650231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
